Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on Preventing Atrial Fibrillation Recurrence After Cardioversion Using Dapagliflozin in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study on Amiodarone for Patients with Persistent Atrial Fibrillation Undergoing Electrical Cardioversion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Aspirin and Clopidogrel for Patients with Atrial Fibrillation After Left Atrial Appendage Closure

    Recruiting

    3 1 1 1
    France
  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid for Patients with Atrial Fibrillation Undergoing Left Atrial Appendage Closure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

    Recruiting

    3 1 1 1
    Belgium Denmark Finland France Germany Greece +5
  • Study on Atorvastatin’s Effect on Preventing Atrial Fibrillation in Patients Undergoing Surgical Aortic Valve Replacement

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on the Safety and Effectiveness of Apixaban and Warfarin for Patients with End-Stage Renal Disease on Peritoneal Dialysis and Atrial Fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on Edoxaban and Drug Combination for Patients with Atrial Fibrillation Needing Anticoagulation After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Germany
  • Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

    Recruiting

    3 1 1
    Investigated Drugs:
    Czechia Denmark Sweden